INVO Fertility, Inc.(IVF)Earnings, Financials & Key Ratios
IVF•NASDAQ
$1.82
$3M mkt cap·Price updated May 7, 2026
AboutINVO Fertility, Inc. operates as a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. The company was founded on January 5, 2007 and is headquartered in Sarasota, FL.Show more
- Revenue$7M+116.3%
- EBITDA-$7M-9.7%
- Net Income-$9M-13.2%
- EPS (Diluted)-219.56+55.2%
- Gross Margin44%+22.4%
- EBITDA Margin-110.32%+49.3%
- Operating Margin-124.4%+44.5%
- Net Margin-139.25%+47.6%
- ROE-133.37%+85.2%
- ROIC-42.23%+66.0%
- Debt/Equity0.78-89.0%
- Interest Coverage-7.63+0.2%
IVF Key Insights
INVO Fertility, Inc. (IVF) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 34.6%
- ✓Trading at only 0.0x book value
✗Weaknesses
- ✗Profits declining 33.2% over 5 years
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 2 (bottom 2%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Shares diluted 100.0% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
IVF Price & Volume
INVO Fertility, Inc. (IVF) stock price & volume — 10-year historical chart
Loading chart...
IVF Growth Metrics
INVO Fertility, Inc. (IVF) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years81.77%
5 Years34.57%
3 Years16.23%
TTM11.5%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-287.79%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-341.11%
Return on Capital
10 Years-196.14%
5 Years-113.88%
3 Years-129.27%
Last Year-41.64%
IVF Peer Comparison
INVO Fertility, Inc. (IVF) competitors in Device suppliers, distribution, and services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 NTRA | 31.16B | 219.82 | -144.62 | 35.9% | -9.03% | -15.28% | 0.13 | |
 PGNY | 1.57B | 19.16 | 29.48 | 10.4% | 5.23% | 13.34% | 0.05 | |
 INMD | 881.95M | 13.92 | 9.73 | -6.16% | 23.27% | 13.28% | 0.02 | |
 MARA | 4.83B | 12.70 | -3.44 | 38.2% | -30.54% | 1.05 | ||
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 11.01% | 0.52 | |
 QDEL | 733.24M | 10.77 | -0.65 | -1.89% | -45.57% | -56.31% | 1.46 | |
 TNDM | 1.27B | 18.47 | -6.08 | 7.93% | -9.2% | -68.29% | 2.86 | |
 LH | 21.24B | 258.04 | 24.67 | 7.25% | 6.66% | 10.89% | 0.83 |
Compare IVF vs Peers
INVO Fertility, Inc. (IVF) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
IVF Income Statement
INVO Fertility, Inc. (IVF) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 50.9K | 282.14K | 494.38K | 1.48M | 1.04M | 4.16M | 822.2K | 3.02M | 6.53M | 6.94M |
| Revenue Growth % | 335.46% | 454.3% | 75.22% | 199.41% | -29.92% | 301.06% | -80.24% | 267.38% | 116.25% | 11.5% |
| Cost of Goods Sold | 15.09K | 51.95K | 90.37K | 139.67K | 88.76K | 145.05K | 850.77K | 1.93M | 3.66M | 4.22M |
| COGS % of Revenue | 29.65% | 18.41% | 18.28% | 9.44% | 8.56% | 3.49% | 103.48% | 64.04% | 56% | - |
| Gross Profit | 35.81K▲ 0% | 230.19K▲ 542.9% | 404.01K▲ 75.5% | 1.34M▲ 231.8% | 948.53K▼ 29.2% | 4.02M▲ 323.3% | -28.57K▼ 100.7% | 1.09M▲ 3901.1% | 2.87M▲ 164.6% | 2.72M▲ 0% |
| Gross Margin % | 70.35% | 81.59% | 81.72% | 90.56% | 91.44% | 96.51% | -3.48% | 35.96% | 44% | 39.17% |
| Gross Profit Growth % | 823.1% | 542.87% | 75.51% | 231.81% | -29.24% | 323.3% | -100.71% | 3901.14% | 164.63% | - |
| Operating Expenses | 2.15M | 870.61K | 3.04M | 3.13M | 6.46M | 9.23M | 10.6M | 7.65M | 11M | 28.43M |
| OpEx % of Revenue | 4216.46% | 308.57% | 614.53% | 211.36% | 623.12% | 221.91% | 1288.98% | 253.34% | 168.4% | - |
| Selling, General & Admin | 2.15M | 870.61K | 3.04M | 3.13M | 6.07M | 9.02M | 9.98M | 7.49M | 9.08M | 10.35M |
| SG&A % of Revenue | 4216.46% | 308.57% | 614.53% | 211.36% | 584.71% | 216.7% | 1213.4% | 247.85% | 138.99% | - |
| Research & Development | 0 | 0 | 0 | 0 | 398.43K | 216.43K | 544.04K | 165.94K | 489.66K | 750.44K |
| R&D % of Revenue | - | - | - | - | 38.41% | 5.2% | 66.17% | 5.49% | 7.5% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 77.3K | 200.89K | 1.43M | 2.88M |
| Operating Income | -2.11M▲ 0% | -640.42K▲ 69.7% | -2.63M▼ 311.3% | -1.79M▲ 32.1% | -5.51M▼ 208.4% | -5.22M▲ 5.4% | -10.63M▼ 103.7% | -6.77M▲ 36.3% | -8.13M▼ 20.1% | -25.71M▲ 0% |
| Operating Margin % | -4146.12% | -226.98% | -532.81% | -120.8% | -531.67% | -125.39% | -1292.45% | -224.04% | -124.4% | -370.24% |
| Operating Income Growth % | -254.65% | 69.65% | -311.3% | 32.12% | -208.43% | 5.41% | -103.71% | 36.32% | -20.07% | - |
| EBITDA | -2.11M | -637.61K | -2.63M | -1.76M | -5.48M | -5.05M | -10.55M | -6.57M | -7.21M | -24.94M |
| EBITDA Margin % | -4142.43% | -225.99% | -531.76% | -119.09% | -528.35% | -121.4% | -1283.05% | -217.38% | -110.32% | -359.11% |
| EBITDA Growth % | -257.72% | 69.76% | -312.3% | 32.95% | -210.91% | 7.85% | -108.88% | 37.76% | -9.74% | -416.41% |
| D&A (Non-Cash Add-back) | 1.88K | 2.81K | 5.19K | 25.35K | 34.48K | 166.08K | 77.3K | 200.89K | 919.6K | 772.75K |
| EBIT | -2.11M | -681.29K | -2.63M | -1.79M | -5.51M | -5.38M | -10.83M | -7.08M | -8.06M | -25.16M |
| Net Interest Income | -13.84K | -20.87K | -442.03K | -379.02K | -2.83M | -1.26M | -59.14K | -925.91K | -1.06M | -910.22K |
| Interest Income | 0 | 0 | 0 | 0 | 4.19K | 3.66K | 308 | 0 | 0 | 0 |
| Interest Expense | 13.84K | 20.87K | 442.03K | 379.02K | 2.84M | 1.27M | 59.45K | 925.91K | 1.06M | 910.22K |
| Other Income/Expense | -13.84K | -61.74K | -442.03K | -379.02K | -2.83M | -1.43M | -263.16K | -1.24M | -993.25K | -1.23M |
| Pretax Income | -2.12M▲ 0% | -702.16K▲ 66.9% | -3.08M▼ 338.1% | -2.17M▲ 29.5% | -8.35M▼ 285.2% | -6.65M▲ 20.3% | -10.89M▼ 63.7% | -8.01M▲ 26.5% | -9.12M▼ 13.9% | -26.93M▲ 0% |
| Pretax Margin % | -4173.3% | -248.87% | -622.22% | -146.41% | -804.72% | -159.86% | -1324.46% | -265.08% | -139.6% | -387.89% |
| Income Tax | 0 | 0 | 0 | 433 | 36 | 4.76K | 2.87K | 27.79K | -22.91K | -54.01K |
| Effective Tax Rate % | 0% | 0% | 0% | -0.02% | -0% | -0.07% | -0.03% | -0.35% | 0.25% | 0.2% |
| Net Income | -2.12M▲ 0% | -702.16K▲ 66.9% | -3.08M▼ 338.1% | -2.17M▲ 29.5% | -8.35M▼ 285.1% | -6.65M▲ 20.3% | -10.89M▼ 63.7% | -8.03M▲ 26.2% | -9.1M▼ 13.2% | -28.96M▲ 0% |
| Net Margin % | -4173.3% | -248.87% | -622.22% | -146.43% | -804.73% | -159.97% | -1324.81% | -266% | -139.25% | -417.01% |
| Net Income Growth % | 57.17% | 66.95% | -338.09% | 29.54% | -285.1% | 20.27% | -63.68% | 26.24% | -13.21% | -287.79% |
| Net Income (Continuing) | -2.12M | -702.16K | -3.08M | -2.17M | -8.35M | -6.65M | -10.89M | -8.03M | -9.1M | -26.88M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.93▲ 0% | -0.96▲ 67.3% | -3.87▼ 303.8% | -2.69▲ 30.5% | -9.21▼ 242.7% | -1099.64▼ 11836.9% | -1570.91▼ 42.9% | -489.96▲ 68.8% | -219.56▲ 55.2% | -20.36▲ 0% |
| EPS Growth % | 58.23% | 67.32% | -303.8% | 30.49% | -242.73% | -11836.84% | -42.86% | 68.81% | 55.19% | -341.11% |
| EPS (Basic) | -2.93 | -0.96 | -3.87 | -2.69 | -9.21 | -1099.64 | -1570.91 | -489.96 | -219.56 | - |
| Diluted Shares Outstanding | 724.95K | 732.87K | 795.57K | 806K | 905.8K | 6.09K | 6.94K | 16.4K | 42.56K | 1.42M |
| Basic Shares Outstanding | 724.95K | 732.87K | 795.57K | 806K | 905.8K | 6.09K | 6.94K | 16.4K | 42.56K | 1.42M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
IVF Balance Sheet
INVO Fertility, Inc. (IVF) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 251.39K | 234.38K | 731.11K | 1.54M | 10.54M | 6.31M | 621.09K | 1.26M | 1.32M | 1.14M |
| Cash & Short-Term Investments | 152.4K | 25.76K | 212.24K | 1.24M | 10.1M | 5.68M | 90.14K | 232.42K | 741.4K | 355.89K |
| Cash Only | 152.4K | 25.76K | 212.24K | 1.24M | 10.1M | 5.68M | 90.14K | 232.42K | 741.4K | 355.89K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 2.79K | 86.7K | 225.9K | 7.56K | 21.7K | 50.47K | 77.15K | 140.55K | 174.88K | 274.2K |
| Days Sales Outstanding | 20.04 | 112.16 | 166.78 | 1.86 | 7.64 | 4.43 | 34.25 | 16.98 | 9.77 | 11.37 |
| Inventory | 85.21K | 58.88K | 43.51K | 101.39K | 265.37K | 287.77K | 263.6K | 264.51K | 219.76K | 191.76K |
| Days Inventory Outstanding | 2.06K | 413.65 | 175.75 | 264.95 | 1.09K | 724.13 | 113.09 | 49.91 | 21.93 | 18.16 |
| Other Current Assets | 0 | 0 | 0 | 195.91K | 0 | 0 | 190.2K | 622.29K | 182.29K | 0 |
| Total Non-Current Assets | 34.84K | 32.03K | 46.24K | 252.04K | 404.81K | 4.16M | 3.09M | 17.25M | 45.13M | 17.7M |
| Property, Plant & Equipment | 15.7K | 15.7K | 34.45K | 194.94K | 211.53K | 2.54M | 1.85M | 4.19M | 2.75M | 2.5M |
| Fixed Asset Turnover | 3.24x | 17.97x | 14.35x | 7.59x | 4.90x | 1.64x | 0.44x | 0.72x | 2.37x | 2.64x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.88M | 23.54M | 5.88M |
| Intangible Assets | 19.14K | 16.33K | 11.79K | 57.1K | 94.96K | 132.09K | 0 | 4.09M | 18.1M | 1.43M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 98.08K | 1.49M | 1.24M | 3.09M | 740.76K | 7.64M |
| Other Non-Current Assets | 0 | 2 | 0 | 0 | 240 | 0 | 0 | 0 | 0 | 9.61M |
| Total Assets | 286.23K▲ 0% | 266.41K▼ 6.9% | 777.35K▲ 191.8% | 1.8M▲ 131.0% | 10.95M▲ 509.7% | 10.47M▼ 4.4% | 3.71M▼ 64.6% | 18.51M▲ 398.8% | 46.45M▲ 151.0% | 18.83M▲ 0% |
| Asset Turnover | 0.18x | 1.06x | 0.64x | 0.82x | 0.09x | 0.40x | 0.22x | 0.16x | 0.14x | 0.24x |
| Asset Growth % | -50.63% | -6.92% | 191.78% | 130.98% | 509.72% | -4.39% | -64.55% | 398.84% | 151% | 242.08% |
| Total Current Liabilities | 4.77M | 5.13M | 3.5M | 1.5M | 2.29M | 1.25M | 3.34M | 8M | 17.93M | 9.24M |
| Accounts Payable | 974.87K | 960.73K | 571.83K | 371.53K | 328.93K | 443.42K | 1.35M | 2.33M | 5.71M | 2.39M |
| Days Payables Outstanding | 23.57K | 6.75K | 2.31K | 970.92 | 1.35K | 1.12K | 578.77 | 439.71 | 570.18 | 326.6 |
| Short-Term Debt | 220.89K | 210.89K | 395.59K | 21.36K | 693.68K | 0 | 762.64K | 1.51M | 6.34M | 1.03M |
| Deferred Revenue (Current) | 0 | 0 | 18.89K | 714.29K | 714.29K | 5.9K | 119.88K | 408.77K | 602.36K | 2.16M |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 527.33K | 581.69K | 946.26K | 1.07M | 2.53M | 5.22M |
| Current Ratio | 0.05x | 0.05x | 0.21x | 1.03x | 4.61x | 5.03x | 0.19x | 0.16x | 0.07x | 0.07x |
| Quick Ratio | 0.03x | 0.03x | 0.20x | 0.96x | 4.49x | 4.80x | 0.11x | 0.12x | 0.06x | 0.06x |
| Cash Conversion Cycle | -21.49K | -6.22K | -1.97K | -704.1 | -253.72 | -387.24 | -431.43 | -372.82 | -538.48 | -297.07 |
| Total Non-Current Liabilities | 131.72K | 131.72K | 0 | 4.01M | 2.92M | 1.9M | 1.35M | 9.61M | 15.78M | 3.74M |
| Long-Term Debt | 131.72K | 131.72K | 0 | 354.61K | 0 | 0 | 0 | 1.25M | 1.13M | 951.67K |
| Capital Lease Obligations | 0 | 0 | 0 | 81.49K | 58.63K | 1.9M | 1.35M | 3.36M | 2.19M | 8.36M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 433 | 469 | 1.14K | 1.95K | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5M | 12.46M | 20.86M |
| Total Liabilities | 4.9M | 5.26M | 3.5M | 5.51M | 5.2M | 3.16M | 4.69M | 17.61M | 33.7M | 12.98M |
| Total Debt | 352.61K | 342.61K | 395.59K | 457.47K | 775.02K | 2.12M | 2.27M | 6.3M | 9.9M | 4.23M |
| Net Debt | 200.21K | 316.85K | 183.35K | -781.12K | -9.32M | -3.56M | 2.18M | 6.07M | 9.15M | 3.88M |
| Debt / Equity | - | - | - | - | 0.13x | 0.29x | - | 7.06x | 0.78x | 0.78x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.17x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.16x |
| Interest Coverage | -152.51x | -32.64x | -5.96x | -4.72x | -1.94x | -4.26x | -182.19x | -7.65x | -7.63x | -27.64x |
| Total Equity | -4.62M▲ 0% | -4.99M▼ 8.1% | -2.72M▲ 45.4% | -3.71M▼ 36.3% | 5.74M▲ 254.7% | 7.31M▲ 27.3% | -977.61K▼ 113.4% | 892.83K▲ 191.3% | 12.75M▲ 1327.8% | 5.85M▲ 0% |
| Equity Growth % | -22.91% | -8.11% | 45.43% | -36.32% | 254.65% | 27.29% | -113.37% | 191.33% | 1327.77% | 59349.91% |
| Book Value per Share | -6.37 | -6.81 | -3.42 | -4.61 | 6.34 | 1200.74 | -140.80 | 54.45 | 299.52 | 4.11 |
| Total Shareholders' Equity | -4.62M | -4.99M | -2.72M | -3.71M | 5.74M | 7.31M | -977.61K | 892.83K | 12.75M | 5.85M |
| Common Stock | 14.06K | 14.21K | 15.43K | 15.63K | 964 | 1.19K | 61 | 249 | 37 | 542 |
| Retained Earnings | -17.94M | -18.65M | -21.72M | -23.89M | -32.24M | -38.89M | -49.78M | -57.82M | -67.16M | -93.09M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IVF Cash Flow Statement
INVO Fertility, Inc. (IVF) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -323.9K | -181.27K | -652.97K | 1.37M | -4.78M | -6.03M | -6.6M | -4.76M | -2.97M | -2.97M |
| Operating CF Margin % | -636.33% | -64.25% | -132.08% | 92.59% | -460.35% | -144.95% | -803.13% | -157.42% | -45.54% | - |
| Operating CF Growth % | -113.62% | 44.04% | -260.22% | 309.89% | -448.42% | -26.28% | -9.51% | 27.99% | 37.45% | -1442.34% |
| Net Income | -2.12M | -702.16K | -3.08M | -2.17M | -8.35M | -6.65M | -10.89M | -8.03M | -9.1M | -28.96M |
| Depreciation & Amortization | 1.88K | 2.81K | 5.19K | 25.35K | 34.48K | 166.08K | 77.3K | 200.89K | 919.6K | 774.49K |
| Stock-Based Compensation | 0 | 0 | 2.09M | 133.54K | 1.76M | 2.71M | 2.22M | 1.39M | 1.59M | 920.7K |
| Deferred Taxes | 0 | 0 | 0 | 433 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.26M | 256K | 366.13K | 431.16K | 2.63M | 1.36M | 505.43K | 1.21M | 1.75M | 19.02M |
| Working Capital Changes | 534.87K | 262.08K | -40.86K | 2.95M | -845.52K | -3.61M | 1.48M | 471.7K | 1.86M | 580.19K |
| Change in Receivables | -1.45K | -83.9K | -139.2K | 218.34K | -14.14K | -28.77K | -26.68K | 0 | -34.33K | -17.15K |
| Change in Inventory | -19.79K | 26.33K | 15.37K | -57.87K | -163.99K | -22.4K | 24.17K | 0 | 44.74K | 49.78K |
| Change in Payables | 82.81K | -5.35K | -377.81K | -200.3K | -42.6K | 114.5K | 904.06K | 924.68K | 1.35M | 375.57K |
| Cash from Investing | -15.7K | 0 | -19.4K | -114.71K | -187.25K | -2.15M | -81.22K | -2.49M | 363.89K | 354.98K |
| Capital Expenditures | -15.7K | 0 | -19.4K | -114.71K | -49.26K | -415.71K | -10.79K | -444.72K | -183.7K | -110.46K |
| CapEx % of Revenue | 30.84% | - | 3.92% | 7.75% | 4.75% | 9.99% | 1.31% | 14.72% | 2.81% | - |
| Acquisitions | 0 | 0 | 0 | 0 | -98.08K | -1.7M | -68.49K | -2.05M | 472.01K | 472.01K |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | -39.91K | -38.94K | -1.94K | 0 | 75.59K | -6.57K |
| Cash from Financing | 0 | 54.63K | 858.86K | -229.47K | 13.82M | 3.77M | 1.09M | 7.39M | 3.12M | 7.19M |
| Debt Issued (Net) | 0 | 0 | 781.86K | -229.47K | 2.35M | -250K | 800K | 1.66M | 409.83K | -755.71K |
| Equity Issued (Net) | 0 | 54.63K | 77K | 0 | 11.48M | 3.65M | 289.8K | 5.73M | 1.81M | 6.92M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 369.84K | 0 | 0 | 900.61K | 1.02M |
| Net Change in Cash | 0▲ 0% | 0▲ 0% | 0▲ 0% | 0▲ 0% | 8.86M▲ 0% | -4.41M▼ 149.8% | -5.59M▼ 26.8% | 142.29K▲ 102.5% | 508.97K▲ 257.7% | -115.7K▲ 0% |
| Free Cash Flow | -339.6K▲ 0% | -181.27K▲ 46.6% | -672.37K▼ 270.9% | 1.31M▲ 294.2% | -4.86M▼ 472.5% | -6.48M▼ 33.3% | -6.62M▼ 2.0% | -5.2M▲ 21.4% | -3.16M▲ 39.3% | -7.77M▲ 0% |
| FCF Margin % | -667.18% | -64.25% | -136% | 88.21% | -468.92% | -155.87% | -804.68% | -172.15% | -48.35% | -111.86% |
| FCF Growth % | -123.98% | 46.62% | -270.92% | 294.19% | -472.53% | -33.32% | -2.03% | 21.41% | 39.26% | -138.87% |
| FCF per Share | -0.47 | -0.25 | -0.85 | 1.62 | -5.37 | -1065.05 | -952.88 | -317.10 | -74.20 | -74.20 |
| FCF Conversion (FCF/Net Income) | 0.15x | 0.26x | 0.21x | -0.63x | 0.57x | 0.91x | 0.61x | 0.59x | 0.33x | 0.27x |
| Interest Paid | 0 | 0 | 0 | 0 | 253.39K | 52.6K | 0 | 9.64K | 214.74K | 416.9K |
| Taxes Paid | 0 | 0 | 0 | 0 | 1.06K | 3.31K | 800 | 0 | 0 | 0 |
IVF Key Ratios
INVO Fertility, Inc. (IVF) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | - | -822.59% | -101.96% | -343.99% | -899.91% | -133.37% | -471.55% |
| Return on Invested Capital (ROIC) | - | - | - | - | - | -4610.16% | -321.89% | -124.33% | -42.23% | -42.23% |
| Gross Margin | 70.35% | 81.59% | 81.72% | 90.56% | 91.44% | 96.51% | -3.48% | 35.96% | 44% | 39.17% |
| Net Margin | -4173.3% | -248.87% | -622.22% | -146.43% | -804.73% | -159.97% | -1324.81% | -266% | -139.25% | -417.01% |
| Debt / Equity | - | - | - | - | 0.13x | 0.29x | - | 7.06x | 0.78x | 0.78x |
| Interest Coverage | -152.51x | -32.64x | -5.96x | -4.72x | -1.94x | -4.26x | -182.19x | -7.65x | -7.63x | -27.64x |
| FCF Conversion | 0.15x | 0.26x | 0.21x | -0.63x | 0.57x | 0.91x | 0.61x | 0.59x | 0.33x | 0.27x |
| Revenue Growth | 335.46% | 454.3% | 75.22% | 199.41% | -29.92% | 301.06% | -80.24% | 267.38% | 116.25% | 11.5% |
IVF Frequently Asked Questions
INVO Fertility, Inc. (IVF) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
INVO Fertility, Inc. (IVF) reported $6.9M in revenue for fiscal year 2024.
INVO Fertility, Inc. (IVF) grew revenue by 116.3% over the past year. This is strong growth.
INVO Fertility, Inc. (IVF) reported a net loss of $29.0M for fiscal year 2024.
Dividend & Returns
INVO Fertility, Inc. (IVF) has a return on equity (ROE) of -133.4%. Negative ROE indicates the company is unprofitable.
INVO Fertility, Inc. (IVF) had negative free cash flow of $7.8M in fiscal year 2024, likely due to heavy capital investments.
Explore More IVF
INVO Fertility, Inc. (IVF) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates